The latest price target for Rapid Micro Biosystems (NASDAQ:RPID) was reported by Keybanc on February 12, 2025. The analyst firm set a price target for $8.00 expecting RPID to rise to within 12 months (a possible 156.41% upside). 1 analyst firms have reported ratings in the last year.

The latest analyst rating for Rapid Micro Biosystems (NASDAQ:RPID) was provided by Keybanc, and Rapid Micro Biosystems initiated their overweight rating.

There is no last upgrade for Rapid Micro Biosystems

The last downgrade for Rapid Micro Biosystems Inc happened on August 16, 2022 when JP Morgan changed their price target from N/A to N/A for Rapid Micro Biosystems Inc.

Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Rapid Micro Biosystems, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Rapid Micro Biosystems was filed on February 12, 2025 so you should expect the next rating to be made available sometime around February 12, 2026.

While ratings are subjective and will change, the latest Rapid Micro Biosystems (RPID) rating was a initiated with a price target of $0.00 to $8.00. The current price Rapid Micro Biosystems (RPID) is trading at is $3.12, which is within the analyst’s predicted range.